Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001477932-25-004757
Filing Date
2025-06-23
Accepted
2025-06-23 16:11:53
Documents
8
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K betrf_6k.htm 6-K 11207
2 NOTICE OF ANNUAL GENERAL MEETING AND INFORMATION betrf_ex991.htm EX-99.1 174352
3 FORM OF PROXY AND RETURN CARD betrf_ex992.htm EX-99.2 67278
4 NOTICE AND ACCESS betrf_ex993.htm EX-99.3 16786
5 betrf_ex992img2.jpg GRAPHIC 5362
6 betrf_ex992img3.jpg GRAPHIC 3536
7 betrf_ex992img4.jpg GRAPHIC 1924
8 betrf_ex992img5.jpg GRAPHIC 3551
  Complete submission text file 0001477932-25-004757.txt   291173
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 438-884-8841
BetterLife Pharma Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 333-161157 | Film No.: 251065080
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)